151 related articles for article (PubMed ID: 18289622)
1. Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor.
Filardo EJ; Quinn JA; Sabo E
Steroids; 2008 Oct; 73(9-10):870-3. PubMed ID: 18289622
[TBL] [Abstract][Full Text] [Related]
2. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.
Filardo EJ
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):231-8. PubMed ID: 11897506
[TBL] [Abstract][Full Text] [Related]
4. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30.
Quinn JA; Graeber CT; Frackelton AR; Kim M; Schwarzbauer JE; Filardo EJ
Mol Endocrinol; 2009 Jul; 23(7):1052-64. PubMed ID: 19342448
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
6. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
Thomas P; Pang Y; Filardo EJ; Dong J
Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
[TBL] [Abstract][Full Text] [Related]
8. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
Schmidt-Wolf R; Zissel G
Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
[TBL] [Abstract][Full Text] [Related]
9. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release.
Filardo EJ; Thomas P
Trends Endocrinol Metab; 2005 Oct; 16(8):362-7. PubMed ID: 16125968
[TBL] [Abstract][Full Text] [Related]
10. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
11. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus.
Cheng SB; Graeber CT; Quinn JA; Filardo EJ
Steroids; 2011 Aug; 76(9):892-6. PubMed ID: 21354433
[TBL] [Abstract][Full Text] [Related]
12. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption.
Thomas P; Dong J
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):175-9. PubMed ID: 17088055
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
14. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane.
Filardo E; Quinn J; Pang Y; Graeber C; Shaw S; Dong J; Thomas P
Endocrinology; 2007 Jul; 148(7):3236-45. PubMed ID: 17379646
[TBL] [Abstract][Full Text] [Related]
15. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.
Vivacqua A; Lappano R; De Marco P; Sisci D; Aquila S; De Amicis F; Fuqua SA; Andò S; Maggiolini M
Mol Endocrinol; 2009 Nov; 23(11):1815-26. PubMed ID: 19749156
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor 30 in tumor development.
Wang D; Hu L; Zhang G; Zhang L; Chen C
Endocrine; 2010 Aug; 38(1):29-37. PubMed ID: 20960099
[TBL] [Abstract][Full Text] [Related]
18. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.
Prossnitz ER; Arterburn JB; Smith HO; Oprea TI; Sklar LA; Hathaway HJ
Annu Rev Physiol; 2008; 70():165-90. PubMed ID: 18271749
[TBL] [Abstract][Full Text] [Related]
19. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression.
Filardo EJ; Graeber CT; Quinn JA; Resnick MB; Giri D; DeLellis RA; Steinhoff MM; Sabo E
Clin Cancer Res; 2006 Nov; 12(21):6359-66. PubMed ID: 17085646
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
